Rachel Eren

1.0k citations
21 papers · 668 indexed · h-index 13
Topics
Hepatitis B Virus Studies (9 papers)Hepatitis C virus research (6 papers)Liver Disease Diagnosis and Treatment (5 papers)

In The Last Decade

Rachel Eren

21 papers receiving 644 citations

Peers

Rachel Eren
Comparison fields: 5 of 69
  • Epidemiology 430
  • Hepatology 380
  • Immunology 155
  • Molecular Biology 98
  • Infectious Diseases 75
Replace J. D. Conradie with:
J. D. Conradie South Africa
Frantisek Sandor Slovakia
Élodie Beaumont France
Alireza Saeidi Malaysia
Maria G. Canese Italy
Fengfeng Mao China
Michiaki Okada Japan
Julia Hengst Germany
Marie B. Iversen Denmark
M W Steward United Kingdom
Rachel Eren relative to J. D. Conradie South Africa J. D. Conradie's profile →
Citations per field
00.5×8.5×
J. D. Conradie · 1×
Citations per year

Countries citing papers authored by Rachel Eren

Since Specialization
Citations

This map shows the geographic impact of Rachel Eren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Eren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Eren more than expected).

Fields of papers citing papers by Rachel Eren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Eren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Eren. The network helps show where Rachel Eren may publish in the future.

Co-authorship network of co-authors of Rachel Eren

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Eren. A scholar is included among the top collaborators of Rachel Eren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Eren. Rachel Eren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 60
3 25
4 82
5 12
6 12
7 30
8 30
9
Therapeutic antibodies against viral hepatitis.
14
10 65
11 69
12
The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases.
9
13 66
14 81
15 7
16 28
17 11
18 48
19 10
20 2

About Rachel Eren

Rachel Eren is a scholar working on Hepatology, Epidemiology and Immunology, having authored 21 papers that have together received 668 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (380 citations), Epidemiology (430 citations) and Immunology (155 citations). Rachel Eren has collaborated with scholars based in Israel, United States and Sweden. Frequent co-authors include Shlomo Dagan, Amiela Globerson, Eithan Galun, Loya Abel, Dorit Zharhary, Ido Lubin, Ofer Nussbaum, Lewis F. Neville, Ehud Ilan and Daniel Shouval. Their work appears in journals such as Hepatology, The Journal of Infectious Diseases and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026